Conference Coverage

Bloating. Flatulence. Think SIBO


 

EXPERT ANALYSIS FROM RWCS 2018

Alternatives to rifaximin include amoxicillin/clavulanic acid in combination with metronidazole.

Two measures she routinely recommends to forestall recurrent SIBO are to have patients start probiotics after a course of rifaximin, and also to try the low-FODMAP (fermentable oligo-di-monosaccharides and polyols) diet. The evidence base in SIBO is weak, but the anecdotal experience has been strongly positive.

“These are two interventions you can provide to your patients with a lot of bloating and gas. It’ll make them feel much, much better,” the gastroenterologist said.

FODMAPs are short-chain carbohydrates, and the low-FODMAP diet is an elimination diet. The first 6 weeks are highly restrictive, then the foods on the high FODMAP list are reintroduced one at a time until the offenders are identified. The low-FODMAP diet hasn’t been conclusively proven effective for SIBO in a randomized clinical trial, but it does have a compelling evidence base for treatment of irritable bowel syndrome diarrhea (J Gastroenterol Hepatol. 2010 Feb;25[2]:252-8).

Pages

Recommended Reading

Opioid use higher in adults with health conditions
MDedge Rheumatology
Award for best hospital goes to … the Mayo Clinic
MDedge Rheumatology
FDA approves second adalimumab biosimilar for multiple conditions
MDedge Rheumatology
CREST syndrome and PBC are often associated
MDedge Rheumatology
PBC linked to increased risk of bone fracture
MDedge Rheumatology
Launch of adalimumab biosimilar Amjevita postponed
MDedge Rheumatology
PBC linked to low BMD, increased risk of osteoporosis
MDedge Rheumatology
Biosimilars poised to save $54 billion over the next decade
MDedge Rheumatology
FDA recommends voluntary recall of Limbrel
MDedge Rheumatology
FDA approves infliximab biosimilar Ixifi for all of Remicade’s indications
MDedge Rheumatology